Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "national-development-strategy"

3 News Found

Prof. Gobardhan Das appointed to NITI Aayog; PM Modi commends his contributions to R&D
People | April 27, 2026

Prof. Gobardhan Das appointed to NITI Aayog; PM Modi commends his contributions to R&D

His appointment is expected to strengthen scientific input in policy discussions across public health, biotech, and translational research

Biostar announces first patient enrolled for Phase 1 study of Utidelone Capsule
News | June 13, 2023

Biostar announces first patient enrolled for Phase 1 study of Utidelone Capsule

UTD2 is the world's first oral epothilone microtubule inhibitor

USFDA approves IND application for Allied’s cancer treatment
Biotech | January 24, 2022

USFDA approves IND application for Allied’s cancer treatment

APS03118 is a novel innovative drug developed by APS with global independent intellectual property rights for unlimited cancer types

Latest Stories

LVPEI launches Eye and Brain Centre in Hyderabad with support from D. E. Shaw India

Indian Immunologicals clocks all-time high revenue of Rs 1,586 crore in FY26

Prof. Gobardhan Das appointed to NITI Aayog; PM Modi commends his contributions to R&D

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
Local manufacturing, deeper CDMO ties, region-specific solutions remain our top priorities in next 3–5 years: Ganesh Bade, Director Bioprocessing–IMEA, Avantor
Local manufacturing, deeper CDMO ties, region-specific solutions remain our top priorities in next 3–5 years: Ganesh Bade, Director Bioprocessing–IMEA, Avantor
Ganesh Bade Director Bioprocessing–IMEA, Avantor
We believe in trust-driven clinical conversations to cut through medical misinformation: Saurav Kasera, Founder, CLIRNET
We believe in trust-driven clinical conversations to cut through medical misinformation: Saurav Kasera, Founder, CLIRNET
Saurav Kasera Founder, CLIRNET
Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group
Only 4-5 Indian pharma companies have a strong presence in Russia, opportunity is far bigger now: Manish Kumar, Vice-Chairman, Moscow Chamber of Commerce, Indian Commission; and President, Soltex Group

Packaging